clinical immuno final1 05

clinical immuno final1 05



34.    Autoantibodies anti—Ro (SS-A) and anti-La (SS-B) are present in majority of patients with

A)    Graves-Basedove disease

B)    Diabetes type I Q Diabetes type II

(D3 Sjogren syndrome E) Miastenia gravis

35.    Allogenic graft:

A) It is for example graft from monkey to human Gł< It is for example graft from mother to daughter

C)    It is for example graft within homozygotic twins

D)    Is usually rejected

36.    Donor-recipient matching as a result of MHC typing is required in transplantatiun of:

A)    Liver and kidney

B)    Kidney and bonę marrow

C)    Bonę marrow and cornea

D)    Heart and liver ^|J>Any organs

37.    Primary immunodeficiency syndrome patients cannot be vaccinated against:

A)    Tuberculossis


B)    Measles    • ‘

"C> Chicken pox

D) Rubella

38.    Which of features written bellow are characteristic for type III hypersensitivity:

A)    Involvement of mast cells

r^~ B) InvoIvement e of complement system

C) Invo)vement of celi type response /D/Immune complexes deposition in tissues

E) True is b. and d.

39.    Monoclonal antibodies:

C£yDo not differ from normal, typical antibodies

B)    Are not suitable for conjugation with immunotoxins

C)    Do not aćtivate complement Cascade

D)    Are produced by hybrids of two lymphocytes with different specificity

E)    Murine ones are morę difficult to produce then human ones

40. ęasitive selection is the process in which

A


Kj/thymocytes whose TCRs bmd self- MHC molecules are permitted to survive

B)    thymocytes whose TCRs bind non-self-MHC molecules are permitted to survive

C)    thymocytes become self-tolerant

D)    thymocytes become autoreactive

/


Wyszukiwarka

Podobne podstrony:
clinical immuno final1 01 Clinical Immunology Finał Test 1. Which of the following diseases is organ
clinical immuno final1 02 /8. The most common form of primary glomerulonephritis in western countrie
clinical immuno final1 03 Mouse MHC molecules are: P2-microglobulin H-2 HLA-DR, -DP, and -DQ HLA-A.
clinical immuno final1 04 25. Uendritic cells: (&} originate form bonę marrow B)   &nb
skanuj0015 6 niepełnosprawne °iat5 ‘6 24 25 34 "5 *4 45-54 SS 64 65 74 więcej w odsetkach dan
2012 06 05 34 10 1 1. Próbka 3 moli ---1, od objętości S litrów i dJFf. i-2- Obiiczyd średnie ciepł
2012 06 05 34 17 cnie Yveodwtaca veVt 4-    ™oina poJiczyć wykonana pracą w przenu g
I I I I I    1—p    I I I I I I0.308 11.68 23.05 34.41 45.78 57.1
05 (34) Wirusy i bakterie Zadanie 1 (1 pkt.) ■S Wybierz i podkreśl prawidłową odpowiedź. Materiałem
Adr«-ł do korcipomhmfi:TAURON DYSTRYBUCJA Gliwice, dnia 25.05.2015 TDOGL/OMI/SS/15 ENERGOAPARATURA
2011 10 05 34 28 W1399 roku ob!tózono n
Polish Society for Fundamental and Clinical Immunology POLSKIE TOWARZYSTWO IMMUNOLOGII DOŚWIADC

więcej podobnych podstron